Veli-Pekka Harjola suomalainen meloja
Harjola, Veli-Pekka
VIAF ID: 1622148209326500460005 (Personal)
Permalink: http://viaf.org/viaf/1622148209326500460005
Preferred Forms
- 100 1 _ ‡a Harjola, Veli-Pekka
-
- 100 0 _ ‡a Veli-Pekka Harjola ‡c suomalainen meloja
4xx's: Alternate Name Forms (6)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut | |
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation | |
Acute heart failure with and without concomitant acute coronary syndromes: patient characteristics, management, and survival | |
Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock | |
Association between elevated blood glucose and outcome in acute heart failure: results from an international observational cohort | |
The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock - Results from the CardShock Study | |
Body mass index and mortality in acutely decompensated heart failure across the world: a global obesity paradox | |
The BRONCH-AHF study: effects on short-term outcome of nebulized bronchodilators in emergency department patients diagnosed with acute heart failure. | |
Combined Measurement of Soluble ST2 and Amino-Terminal Pro-B-Type Natriuretic Peptide Provides Early Assessment of Severity in Cardiogenic Shock Complicating Acute Coronary Syndrome | |
Comparison of the use of comprehensive point-of-care test panel to conventional laboratory process in emergency department | |
Contemporary management of octogenarians hospitalized for heart failure in Europe: Euro Heart Failure Survey II. | |
Corrigendum to 'Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology' [Eur | |
Critically ill patients in emergency department may be characterized by low amplitude and high variability of amplitude of pulse photoplethysmography | |
Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality | |
Cystatin C: a step forward in assessing kidney function and cardiovascular risk | |
Early follow-up of patients with acute heart failure by serial assessment of plasma NT-proBNP further discriminates outcome after hospital discharge | |
Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients | |
Effect of severe renal failure and haemodialysis on the pharmacokinetics of levosimendan and its metabolites. | |
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry | |
Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients | |
Frequency and Prognostic Significance of Abnormal Liver Function Tests in Patients With Cardiogenic Shock | |
Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II | |
Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica | |
Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST | |
Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. | |
Helical computerized tomography and NT-proBNP for screening of right ventricular overload on admission and at long term follow-up of acute pulmonary embolism | |
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. | |
The impact of emergency medical services in acute heart failure | |
Inhaled Xenon Attenuates Myocardial Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The Xe-Hypotheca Trial. | |
International perspectives on emergency department crowding | |
Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial | |
Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry. | |
Management of acute heart failure and the effect of systolic blood pressure on the use of intravenous therapies | |
Markers of renal function and acute kidney injury in acute heart failure: definitions and impact on outcomes of the cardiorenal syndrome. | |
N-terminal Pro-brain Natriuretic Peptide, High-sensitivity Troponin and Pulmonary Artery Clot Score as Predictors of Right Ventricular Dysfunction in Echocardiography. | |
Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. | |
Rapid cardiothoracic ultrasound protocol for diagnosis of acute heart failure in the emergency department. | |
Reduction in membrane component of diffusing capacity is associated with the extent of acute pulmonary embolism | |
Renal effects of levosimendan: a consensus report | |
Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time | |
Response to letter regarding article, "Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation". | |
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. | |
Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction | |
[Specialist training of emergency medicine in a secondary care hospital]. | |
Straightforward emergency care. | |
Treatments targeting inotropy | |
Triage quality control is missing tools-a new observation technique for ED quality improvement | |
The type of acute heart failure and the costs of hospitalization | |
The use of more than one inotrope in acute heart failure is associated with increased mortality: a multi-centre observational study | |
Use of noninvasive and invasive mechanical ventilation in cardiogenic shock: A prospective multicenter study | |
Use of point-of-care testing and early assessment model reduces length of stay for ambulatory patients in an emergency department | |
Ventricular conduction abnormalities as predictors of long-term survival in acute de novo and decompensated chronic heart failure | |
Viral encephalitis associated with pandemic 2009 (H1N1) influenza A. | |
When will a patient with pulmonary embolism be fit to go home? | |
Wytyczne ESC dotyczące diagnostyki i leczenia ostrej i przewlekłej niewydolności serca w 2016 roku |